New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Inventiva S.A.
IVA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

247M

Biotechnology

2.66USD
Shape0.18 ( 7.26%)
favorite-chart

Relative Strenght

33
favorite-chart

Volume Buzz

-74%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

44%

Quote Panel

Shape
Updated October 27, 2024
1W -2.56 % 1M 42.25 % 3M 20.36 % 1Y -28.69 %

Key Metrics

Shape
  • Market Cap

    247.26M


  • Shares Outstanding

    86.90M


  • Share in Float

    84.48M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    2.66


  • Average Volume

    203596


  • Beta

    1.013


  • Range

    1.53-4.75


  • Industry

    Biotechnology


  • Website

    https://www.inventivapharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

9.88x

P/S Ratio

-3.69x

P/B Ratio

-1.0

Debt/Equity

-476.7%

Net Margin

$-2.2

EPS

How IVA compares to sector?

P/E Ratio

Relative Strength

Shape

IVA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$14M

Shape200%

2025-Revenue

$0.75

Shape60%

2025-EPS

$14M

Shape-200%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Societe Generale

upgrade

Previous: Not converted

2023-05-19

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.20

arrow
arrow

N/A

-0.57
vs -0.41

Q1.21

arrow
arrow

N/A

-0.27
vs -0.25

Q2.21

arrow
arrow

N/A

-0.44
vs -0.26

Q4.21

arrow
arrow

N/A

-0.76
vs -0.57

Q2.22

arrow
arrow

N/A

-0.75
vs -0.44

Q4.22

arrow
arrow

N/A

-0.64
vs -0.76

Q2.23

arrow
arrow

N/A

-1.43
vs -0.75

Q4.23

arrow
arrow

N/A

-1.25
vs -0.64

Q1.24

arrow
arrow

N/A

1.45
vs NA

Q2.24

arrow
arrow

N/A

-0.75
vs -1.43

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.20

arrow
arrow

-96%

211K  vs 5.7M

Q1.21

arrow
arrow

-15%

74K  vs 87K

Q2.21

arrow
arrow

-12%

65K  vs 74K

Q4.21

arrow
arrow

+1822%

4.1M  vs 211K

Q2.22

arrow
arrow

+3%

67K  vs 65K

Q4.22

arrow
arrow

+280%

15.4M  vs 4.1M

Q2.23

arrow
arrow

+9784%

6.6M  vs 67K

Q4.23

arrow
arrow

+7%

16.5M  vs 15.4M

Q1.24

arrow
arrow

NA

17.9M  vs NA

Q2.24

arrow
arrow

-81%

1.2M  vs 6.6M

Return on EquityShape

status-upQoQ

Q1.21

arrow
arrow

-9%

-0.09
vs -0.16

Q2.21

arrow
arrow

-16%

-0.16
vs -0.09

Q4.21

arrow
arrow

-30%

-0.30
vs -0.16

Q2.22

arrow
arrow

-42%

-0.42
vs -0.30

Q4.22

arrow
arrow

NA

NA
vs -0.42

Q4.22

arrow
arrow

-55%

-0.55
vs NA

Q2.23

arrow
arrow

+721%

7.21
vs -0.55

Q4.23

arrow
arrow

+170%

1.7
vs 7.21

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

7

7
vs 10

-30%

Q4.22

arrow
arrow

7

7
vs 7

NA

Q1.23

arrow
arrow

7

7
vs 7

NA

Q2.23

arrow
arrow

7

7
vs 7

NA

Q3.23

arrow
arrow

6

6
vs 7

-14%

Q4.23

arrow
arrow

7

7
vs 6

17%

Q1.24

arrow
arrow

8

8
vs 7

14%

Q2.24

arrow
arrow

7

7
vs 8

-12%

Earnings Growth

Latest News